cletoquine has been researched along with hydroxychloroquine in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Iredale, J; Wainer, IW | 1 |
| Khalil, SK; Miller, DR; Nygard, GA | 1 |
| Hawk, JL; Magnus, IA; Murphy, GM | 1 |
| Benziger, DP; Brown, RR; Stroshane, RM | 1 |
| Cutler, DJ; McLachlan, AJ; Tett, SE | 1 |
| Ducharme, J; Ducharme, MP; Fieger, H; Khalil, SK; Wainer, IW | 1 |
| Baethge, BA; Botstein, GR; Caldwell, J; Dietz, F; Ettlinger, R; Furst, DE; Gibbs, JP; Golden, HE; Lindsley, H; McLaughlin, GE; Moreland, LW; Munster, T; Roberts, WN; Rooney, TW; Rothschild, B; Sack, M; Sebba, AI; Shen, D; Weisman, M; Welch, KE; Yocum, D | 1 |
| Adoue, D; Arlet, P; Blancher, A; Castex, JO; Fournie, B; Lapeyre-Mestre, M; Méliani, P; Montastruc, JL; Pourrat, J; Puissant, B; Sailler, L; Saivin, S | 1 |
| Baud, FJ; Bourgogne, E; Chevillard, L; Fonsart, J; Houzé, P; Laprévote, O; Mégarbane, B; Soichot, M | 1 |
| Chung, YJ; Han, K; Ju, JH; Jung, SH; Kwok, SK; Lee, JY; Park, KS; Park, SH; Park, SW; Vinayagamoorthy, N | 1 |
| Hyeon Ju, J; Ki Kwok, S; Lee, J; Park, SH; Su Park, K; Yeon Lee, J | 1 |
| Amoura, Z; Combarel, D; Funck-Brentano, C; Lori, L; Noé, G; Seycha, A; Tissot, N; Zahr, N | 1 |
| Aweeka, F; Gingrich, D; Huang, L; Marzan, F; Sok, V | 1 |
| Agrawal, V; Arnold, SLM; Barnabas, RV; Bershteyn, A; Chhonker, YS; Heller, KB; Johnston, C; Krows, ML; Landovitz, R; Laufer, M; Leingang, H; Murry, DJ; Paasche-Orlow, M; Stankiewicz Karita, HC; Steinbronn, C; Stewart, J; Wener, M | 1 |
1 trial(s) available for cletoquine and hydroxychloroquine
| Article | Year |
|---|---|
Hydroxychloroquine in polymorphic light eruption: a controlled trial with drug and visual sensitivity monitoring.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Female; Hair; Humans; Hydroxychloroquine; Male; Skin Diseases; Sunlight | 1987 |
13 other study(ies) available for cletoquine and hydroxychloroquine
| Article | Year |
|---|---|
Determination of hydroxychloroquine and its major metabolites in plasma using sequential achiral-chiral high-performance liquid chromatography.
Topics: Animals; Biological Availability; Chloroquine; Chromatography, High Pressure Liquid; Hydroxychloroquine; Male; Rabbits; Spectrophotometry, Ultraviolet; Stereoisomerism | 1992 |
Steady-state pharmacokinetics of hydroxychloroquine in rheumatoid arthritis patients.
Topics: Administration, Oral; Arthritis, Rheumatoid; Chloroquine; Female; Half-Life; Humans; Hydroxychloroquine; Male | 1991 |
High-performance liquid chromatographic assay for hydroxychloroquine and three of its major metabolites, desethylhydroxychloroquine, desethylchloroquine and bidesethylchloroquine, in human plasma.
Topics: Chloroquine; Chromatography, High Pressure Liquid; Freezing; Humans; Hydroxychloroquine | 1986 |
Plasma protein binding of the enantiomers of hydroxychloroquine and metabolites.
Topics: Blood Proteins; Chloroquine; Humans; Hydroxychloroquine; Protein Binding; Stereoisomerism | 1993 |
Enantioselective disposition of hydroxychloroquine after a single oral dose of the racemate to healthy subjects.
Topics: Administration, Oral; Adult; Antimalarials; Antirheumatic Agents; Chromatography, High Pressure Liquid; Humans; Hydroxychloroquine; Male; Stereoisomerism | 1995 |
Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Eye Diseases; Gastrointestinal Diseases; Humans; Hydroxychloroquine; Logistic Models; Multicenter Studies as Topic; Oxidation-Reduction; Randomized Controlled Trials as Topic; Retrospective Studies; Severity of Illness Index | 2002 |
Blood concentrations of hydroxychloroquine and its desethyl derivative correlate negatively with the percentage of CD45RO+ cells among CD4+ lymphocytes in hydroxychloroquine-treated lupus patients.
Topics: Adult; Antirheumatic Agents; CD4-Positive T-Lymphocytes; Cell Differentiation; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Humans; Hydroxychloroquine; Leukocyte Common Antigens; Lupus Erythematosus, Systemic; Lymphocyte Activation; Male; T-Lymphocyte Subsets | 2007 |
Development, validation and clinical application of a LC-MS/MS method for the simultaneous quantification of hydroxychloroquine and its active metabolites in human whole blood.
Topics: Adult; Antimalarials; Biotransformation; Calibration; Chromatography, Liquid; Drug Monitoring; Drug Stability; Female; Humans; Hydroxychloroquine; Linear Models; Poisoning; Reference Standards; Reproducibility of Results; Suicide, Attempted; Tandem Mass Spectrometry; Time Factors | 2014 |
Association of Polymorphisms of Cytochrome P450 2D6 With Blood Hydroxychloroquine Levels in Patients With Systemic Lupus Erythematosus.
Topics: Adult; Antirheumatic Agents; Asian People; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Female; Gene Frequency; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Male; Polymorphism, Genetic; Polymorphism, Single Nucleotide | 2016 |
Factors Related to Blood Hydroxychloroquine Concentration in Patients With Systemic Lupus Erythematosus.
Topics: Administration, Oral; Adult; Antirheumatic Agents; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Drug Administration Schedule; Drug Monitoring; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Male; Mass Spectrometry; Middle Aged; Severity of Illness Index; Treatment Outcome | 2017 |
Development and Validation of a Fast Ultra-High Performance Liquid Chromatography-Fluorescent Method for the Quantification of Hydroxychloroquine and Its Metabolites in Patients With Lupus.
Topics: Antirheumatic Agents; Calibration; Chloroquine; Chromatography, High Pressure Liquid; Drug Monitoring; Fluorescence; Humans; Hydroxychloroquine; Indicators and Reagents; Lupus Erythematosus, Systemic; Reproducibility of Results | 2019 |
Development and validation of an LC-MS/MS method for determination of hydroxychloroquine, its two metabolites, and azithromycin in EDTA-treated human plasma.
Topics: Anti-Bacterial Agents; Antimalarials; Azithromycin; Blood Specimen Collection; Chloroquine; Chromatography, High Pressure Liquid; Drug Monitoring; Edetic Acid; Humans; Hydroxychloroquine; Limit of Detection; Tandem Mass Spectrometry | 2021 |
A linked physiologically based pharmacokinetic model for hydroxychloroquine and metabolite desethylhydroxychloroquine in SARS-CoV-2(-)/(+) populations.
Topics: COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Pandemics; SARS-CoV-2 | 2023 |